YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dishman Pharma
Dishman Pharma

17th-Jan-2012 08:52Source: BSE

Dishman Pharma - Acquisition of Creapharm Parenterals

Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that Company's Wholly Owned Subsidiary company, namely Carbogen Amcis AG., Switzerland has acquired Creapharm Parenterals, a subsidiary of France based Greapharm Group.

Creapharm Parenterals is a contract development and manufacturing organization specializing in liquid, semi-solid and injectable aseptic dosage forms. As part of this acquisition, Creapharm Parenterals has changed its name to CARBOGEN AMCIS SAS.

The acquisition will extend CARBOGEN AMCIS' comprehensive range of development and manufacturing services by adding complementary formulation, lyophilization services and sterile GMP capabilities for the fast supply of drug products, including highly potents, for preclinical studies and clinical trials (Phase I, II & III).

More Announcements on:

11th-Aug-2017 16:47Source: BSE

Dishman Pharma - Investor Presentation

24th-Jul-2017 14:36Source: BSE

Dishman Pharma - Updates

21st-Jul-2017 17:38Source: BSE

Dishman Pharma - Updates

12th-Jul-2017 14:42Source: BSE

Dishman Pharma - Updates

1 2 3 4 5 Next >>
Follow us on
Available On